DSG Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Sell
1,090
-120
-10% -$57.6K 0.08% 91
2026
Q1
$595K Sell
1,210
-155
-11% -$84.1K 0.1% 93
2025
Q4
$853K Hold
1,365
0.13% 78
2025
Q3
$662K Hold
1,365
0.11% 87
2025
Q2
$553K Hold
1,365
0.1% 92
2025
Q1
$679K Hold
1,365
0.14% 83
2024
Q4
$710K Buy
+1,365
New +$750K 0.13% 82

Other funds holding TMO

DSG Capital Advisors's TMO Position: Q2 2026 in Review

DSG Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 9.9% in Q2 2026, selling an estimated $57.6K and leaving 1,090 shares worth $582K. The position accounts for 0.08% of the portfolio, ranked #91.

DSG Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $853K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • DSG Capital Advisors held 1,090 shares of Thermo Fisher Scientific worth $582K as of Q2 2026.
  • DSG Capital Advisors sold 120 Thermo Fisher Scientific shares in Q2 2026, an estimated $57.6K.
  • Thermo Fisher Scientific made up 0.08% of DSG Capital Advisors's portfolio in Q2 2026, its #91 holding.
  • DSG Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • DSG Capital Advisors's Thermo Fisher Scientific position peaked at $853K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on DSG Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.